Clinical trial
High Dose Ascorbic Acid Treatment of CMT1A
NCT00484510 · Wayne State University, Other · Completed
Key facts
| NCT number | NCT00484510 |
|---|---|
| Title | High Dose Ascorbic Acid Treatment of CMT1A |
| Official title | A Randomized, Placebo-controlled, Double Masked 120 Subject "Futility Design" Clinical Trial of Ascorbic Acid Treatment of Charcot Marie Tooth Disease Type 1A. |
| Lead sponsor | Wayne State University, Other |
| Collaborators | Muscular Dystrophy Association Charcot-Marie-Tooth Association |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Charcot-Marie-Tooth Disease, Type Ia |
| Intervention type | Drug |
| Interventions | Ascorbic acid (Vitamin C), placebo |
| Enrollment | 110 |
| Start date | Apr 1, 2007 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Jun 11, 2007 |
| Last update posted | Mar 6, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: